News
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Enapter AG sets forecast for financial year 2025 and publishes preliminary figures for 2024
Enapter AG sets forecast for financial year 2025 and publishes preliminary figures for 2024. Company expects revenues between EUR 39 million and EUR 42 million with an EBITDA of between EUR -2 million and EUR +/- 0 -
PRESS RELEASE
EQS-Adhoc: Altech Advanced Materials AG: Transfer of shareholdings in exchange for shares in Altech Batteries Ltd
Altech Advanced Materials AG plans to transfer minority interests in battery project companies to Altech Batteries Ltd in exchange for shares. The move aims to optimize financing options and expedite production facility implementation -
-
-
PRESS RELEASE
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
Xenetic Biosciences announces abstract acceptance for SITC Spring Scientific 2025 Cell Therapy Meeting on targeting Neutrophil Extracellular Traps in Metastatic Melanoma -